Magnus Moliteus
Vorstandsvorsitzender bei KAEL-GemVax Co., Ltd.
Profil
Magnus Moliteus currently works at KAEL-GemVax Co., Ltd., as Chief Executive Officer, COM Consulting, as Chairman from 2001, and Novaflux Technologies, Inc., as Director.
Mr. Moliteus also formerly worked at Procordia Food AB, as Chief Executive Officer in 1995, Pharmacia, Inc., as Chief Executive Officer from 1977 to 1990, Swedish-American Chambers of Commerce of the USA, as Chairman in 1991, DUSA Pharmaceuticals, Inc., as Director from 2003 to 2011, Invest in Sweden Agency, as Executive Director from 1995 to 2001, ACell, Inc., as Director, Fuss Brands Corp., as Director from 2007 to 2008, and Health Industry Manufacturers Association, as Director in 1995.
Mr. Moliteus received his graduate degree from the University of Uppsala.
Aktive Positionen von Magnus Moliteus
Unternehmen | Position | Beginn |
---|---|---|
COM Consulting | Vorsitzender | 01.01.2001 |
KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., KAEL-GemVax Co., Ltd. manufactures bio-pharmaceutical products. The company is based in Seongnam, South Korea. The CEOs of the South Korean company are Gyeong Hee Kim, Sang-Jae Kim, Magnus Moliteus. | Vorstandsvorsitzender | - |
Novaflux Technologies, Inc.
Novaflux Technologies, Inc. Medical SpecialtiesHealth Technology Novaflux Technologies, Inc. develops and manufactures medical devices. Its products include ClearFlux, CleanFlow CIP, Novascope and NF EarTube. The company was founded in 1988 and is headquartered in Princeton, NJ. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Magnus Moliteus
Unternehmen | Position | Ende |
---|---|---|
FUSS BRANDS CORP. | Direktor/Vorstandsmitglied | 19.05.2008 |
Invest in Sweden Agency | Direktor/Vorstandsmitglied | 01.01.2001 |
Procordia Food AB | Präsident | 01.01.1995 |
Health Industry Manufacturers Association | Direktor/Vorstandsmitglied | 01.01.1995 |
Swedish-American Chambers of Commerce of the USA | Vorsitzender | 01.01.1991 |
Ausbildung von Magnus Moliteus
University of Uppsala | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FUSS BRANDS CORP. | Health Technology |
Private Unternehmen | 10 |
---|---|
COM Consulting | |
Invest in Sweden Agency | Government |
Pharmacia, Inc. | |
Procordia Food AB | Consumer Non-Durables |
Swedish-American Chambers of Commerce of the USA | |
Health Industry Manufacturers Association | |
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |
KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., KAEL-GemVax Co., Ltd. manufactures bio-pharmaceutical products. The company is based in Seongnam, South Korea. The CEOs of the South Korean company are Gyeong Hee Kim, Sang-Jae Kim, Magnus Moliteus. | Health Technology |
Novaflux Technologies, Inc.
Novaflux Technologies, Inc. Medical SpecialtiesHealth Technology Novaflux Technologies, Inc. develops and manufactures medical devices. Its products include ClearFlux, CleanFlow CIP, Novascope and NF EarTube. The company was founded in 1988 and is headquartered in Princeton, NJ. | Health Technology |
ACell, Inc.
ACell, Inc. Pharmaceuticals: MajorHealth Technology ACell, Inc. develops and manufactures bioscaffold, extracellular matrix technology for medical and veterinary products. It offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix devices to repair and remodel damaged tissues and organs in a broad range of surgical procedures. The firm's products include ABRA, Cytal Burn Matrix, Cytal Wound Matrix, Gentrix Surgical Matrix and MicroMatrix. It is a regenerative medicine company that focuses on the development, manufacturing and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects. The firm’s products utilizes proprietary porcine urinary bladder matrix platform technology, which is designed to enhance the body's ability to restore natural tissue and minimize scarring in the management of traumatic, surgical and chronic wounds, burns, hernias and other conditions requiring the reinforcement of soft tissue. The company was founded by Stephen Xavier Graham in June 1999 and is headquartered in Columbia, MD. | Health Technology |